کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
5834152 | 1122662 | 2012 | 9 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: Simvastatin delivery via inhalation attenuates airway inflammation in a murine model of asthma Simvastatin delivery via inhalation attenuates airway inflammation in a murine model of asthma](/preview/png/5834152.png)
The dose-response of the pleiotropic effects of statins on airway inflammation has not yet been established and may differ from that of their cholesterol-lowering effects. High oral doses of statins may have adverse effects, and it may be possible to overcome the side effects and low clinical efficacy by administering statins via inhalation. In this study, we hypothesize that simvastatin is a potential anti-inflammatory drug with biological and pharmacokinetic properties suitable for delivery by the inhaled route. Mice were immunized with ovalbumin (OVA) and then challenged with aerosol OVA. Simvastatin was locally delivered by inhalation (i.h.) and intratracheal injection (i.t.) or systematically delivered by intraperitoneal injection (i.p.) and gavage (i.g.) during the OVA challenge. In a mouse model of asthma, i.h. simvastatin significantly and dose-dependently attenuated airway inflammation, remodeling and hyperresponsiveness in a RhoA-dependent pathway. Upon comparing the pharmacodynamics, i.h. simvastatin had a more potent effect than that of i.g. and i.p. simvastatin, and the i.h. or i.t. delivery routes led to a higher drug concentration in local lung tissue and a lower drug concentration in the plasma than that obtained by the i.g. These results suggest that simvastatin is a potential anti-inflammatory drug for airway inflammatory diseases with properties suitable for delivery by inhalation, which will probably reduce the side effects and increase clinical efficacy.
⺠Simvastatin via inhalation delivery attenuates airway inflammation. ⺠Simvastatin via inhalation delivery showed a higher drug concentration in local lung tissue. ⺠Simvastatin is suitable for inhalation delivery. ⺠Simvastatin via inhalation delivery probably overcome the side effect liabilities and efficacy of oral simvastatin.
Journal: International Immunopharmacology - Volume 12, Issue 4, April 2012, Pages 556-564